ECCO Position statement on the use of biosimilars for inflammatory bowel disease-an update

Silvio Danese, Gionata Fiorino, Tim Raine, Marc Ferrante, Karen Kemp, Jaroslaw Kierkus, P. Lakatos, Gerassimos Mantzaris, Janneke van der Woude, Julian Panes, Laurent Peyrin-Biroulet

Research output: Contribution to journalArticle

89 Citations (Scopus)
Original languageEnglish
Pages (from-to)26-34
Number of pages9
JournalJournal of Crohn's and Colitis
Volume11
Issue number1
DOIs
Publication statusPublished - Jan 1 2017

Fingerprint

Biosimilar Pharmaceuticals
Drug Substitution
Gastrointestinal Agents
Inflammatory Bowel Diseases
Infliximab

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Danese, S., Fiorino, G., Raine, T., Ferrante, M., Kemp, K., Kierkus, J., ... Peyrin-Biroulet, L. (2017). ECCO Position statement on the use of biosimilars for inflammatory bowel disease-an update. Journal of Crohn's and Colitis, 11(1), 26-34. https://doi.org/10.1093/ecco-jcc/jjw198

ECCO Position statement on the use of biosimilars for inflammatory bowel disease-an update. / Danese, Silvio; Fiorino, Gionata; Raine, Tim; Ferrante, Marc; Kemp, Karen; Kierkus, Jaroslaw; Lakatos, P.; Mantzaris, Gerassimos; van der Woude, Janneke; Panes, Julian; Peyrin-Biroulet, Laurent.

In: Journal of Crohn's and Colitis, Vol. 11, No. 1, 01.01.2017, p. 26-34.

Research output: Contribution to journalArticle

Danese, S, Fiorino, G, Raine, T, Ferrante, M, Kemp, K, Kierkus, J, Lakatos, P, Mantzaris, G, van der Woude, J, Panes, J & Peyrin-Biroulet, L 2017, 'ECCO Position statement on the use of biosimilars for inflammatory bowel disease-an update', Journal of Crohn's and Colitis, vol. 11, no. 1, pp. 26-34. https://doi.org/10.1093/ecco-jcc/jjw198
Danese, Silvio ; Fiorino, Gionata ; Raine, Tim ; Ferrante, Marc ; Kemp, Karen ; Kierkus, Jaroslaw ; Lakatos, P. ; Mantzaris, Gerassimos ; van der Woude, Janneke ; Panes, Julian ; Peyrin-Biroulet, Laurent. / ECCO Position statement on the use of biosimilars for inflammatory bowel disease-an update. In: Journal of Crohn's and Colitis. 2017 ; Vol. 11, No. 1. pp. 26-34.
@article{f3fc6c690b3c4b70a306cccd2e1f91bb,
title = "ECCO Position statement on the use of biosimilars for inflammatory bowel disease-an update",
author = "Silvio Danese and Gionata Fiorino and Tim Raine and Marc Ferrante and Karen Kemp and Jaroslaw Kierkus and P. Lakatos and Gerassimos Mantzaris and {van der Woude}, Janneke and Julian Panes and Laurent Peyrin-Biroulet",
year = "2017",
month = "1",
day = "1",
doi = "10.1093/ecco-jcc/jjw198",
language = "English",
volume = "11",
pages = "26--34",
journal = "Journal of Crohn's and Colitis",
issn = "1873-9946",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - ECCO Position statement on the use of biosimilars for inflammatory bowel disease-an update

AU - Danese, Silvio

AU - Fiorino, Gionata

AU - Raine, Tim

AU - Ferrante, Marc

AU - Kemp, Karen

AU - Kierkus, Jaroslaw

AU - Lakatos, P.

AU - Mantzaris, Gerassimos

AU - van der Woude, Janneke

AU - Panes, Julian

AU - Peyrin-Biroulet, Laurent

PY - 2017/1/1

Y1 - 2017/1/1

UR - http://www.scopus.com/inward/record.url?scp=85015798741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015798741&partnerID=8YFLogxK

U2 - 10.1093/ecco-jcc/jjw198

DO - 10.1093/ecco-jcc/jjw198

M3 - Article

C2 - 27927718

AN - SCOPUS:85015798741

VL - 11

SP - 26

EP - 34

JO - Journal of Crohn's and Colitis

JF - Journal of Crohn's and Colitis

SN - 1873-9946

IS - 1

ER -